These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 10494132)
21. Isolation of circulating tumor cells by immunomagnetic enrichment and fluorescence-activated cell sorting (IE/FACS) for molecular profiling. Magbanua MJ; Park JW Methods; 2013 Dec; 64(2):114-8. PubMed ID: 23896286 [TBL] [Abstract][Full Text] [Related]
22. Multi-Marker Immunomagnetic Enrichment of Circulating Melanoma Cells. Beasley AB; Acheampong E; Lin W; Gray ES Methods Mol Biol; 2021; 2265():213-222. PubMed ID: 33704717 [TBL] [Abstract][Full Text] [Related]
23. Efficiency of Ber-EP4 antibody for isolating circulating epithelial tumor cells before RT-PCR detection. Sabile A; Louha M; Bonte E; Poussin K; Vona G; Mejean A; Chretien Y; Bougas L; Lacour B; Capron F; Roseto A; Bréchot C; Paterlini-Bréchot P Am J Clin Pathol; 1999 Aug; 112(2):171-8. PubMed ID: 10439796 [TBL] [Abstract][Full Text] [Related]
24. Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is not a reliable tumor marker in melanoma patients: a clinical two-center study. Gläser R; Rass K; Seiter S; Hauschild A; Christophers E; Tilgen W J Clin Oncol; 1997 Aug; 15(8):2818-25. PubMed ID: 9256124 [TBL] [Abstract][Full Text] [Related]
25. Detection of tumor cells in blood using CD45 magnetic cell separation followed by nested mutant allele-specific amplification of p53 and K-ras genes in patients with colorectal cancer. Iinuma H; Okinaga K; Adachi M; Suda K; Sekine T; Sakagawa K; Baba Y; Tamura J; Kumagai H; Ida A Int J Cancer; 2000 Jul; 89(4):337-44. PubMed ID: 10956407 [TBL] [Abstract][Full Text] [Related]
26. Immunomagnetic separation for enrichment and sensitive detection of disseminated tumour cells in patients with head and neck SCC. Partridge M; Phillips E; Francis R; Li SR J Pathol; 1999 Nov; 189(3):368-77. PubMed ID: 10547599 [TBL] [Abstract][Full Text] [Related]
28. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer. Okegawa T; Nutahara K; Higashihara E J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699 [TBL] [Abstract][Full Text] [Related]
29. Isolation and characterization of living circulating tumor cells in patients by immunomagnetic negative enrichment coupled with flow cytometry. Lu Y; Liang H; Yu T; Xie J; Chen S; Dong H; Sinko PJ; Lian S; Xu J; Wang J; Yu S; Shao J; Yuan B; Wang L; Jia L Cancer; 2015 Sep; 121(17):3036-45. PubMed ID: 25945459 [TBL] [Abstract][Full Text] [Related]
30. Facts and pitfalls in the detection of tyrosinase mRNA in the blood of melanoma patients by RT-PCR. Seiter S; Rappl G; Tilgen W; Ugurel S; Reinhold U Recent Results Cancer Res; 2001; 158():105-12. PubMed ID: 11092037 [TBL] [Abstract][Full Text] [Related]
31. Detection of tyrosinase mRNA by RT-PCR in the peripheral blood of patients with advanced metastatic melanoma. Alao JP; Mohammed MQ; Slade MJ; Retsas S Melanoma Res; 1999 Aug; 9(4):395-9. PubMed ID: 10504059 [TBL] [Abstract][Full Text] [Related]
32. Application of immunomagnetic cell enrichment in combination with RT-PCR for the detection of rare circulating head and neck tumor cells in human peripheral blood. Tong X; Yang L; Lang JC; Zborowski M; Chalmers JJ Cytometry B Clin Cytom; 2007 Sep; 72(5):310-23. PubMed ID: 17205568 [TBL] [Abstract][Full Text] [Related]
33. PD-L1 Detection on Circulating Melanoma Cells. Po JW; Ma Y; Balakrishnar B; Brungs D; Azimi F; Cooper A; Saricilar E; Murthy V; de Souza P; Becker TM Methods Mol Biol; 2021; 2265():223-233. PubMed ID: 33704718 [TBL] [Abstract][Full Text] [Related]
34. The use of a panel of monoclonal antibodies to enrich circulating breast cancer cells facilitates their detection. Hager G; Cacsire-Castillo Tong D; Schiebel I; Rezniczek GA; Watrowski R; Speiser P; Zeillinger R Gynecol Oncol; 2005 Aug; 98(2):211-6. PubMed ID: 15967487 [TBL] [Abstract][Full Text] [Related]
35. Biofunctionalized magnetic nanospheres-based cell sorting strategy for efficient isolation, detection and subtype analyses of heterogeneous circulating hepatocellular carcinoma cells. Chen L; Wu LL; Zhang ZL; Hu J; Tang M; Qi CB; Li N; Pang DW Biosens Bioelectron; 2016 Nov; 85():633-640. PubMed ID: 27240010 [TBL] [Abstract][Full Text] [Related]
36. Improvement of breast cancer cell detection by immunomagnetic enrichment. Krüger W; Tögel F; Rössing S; Kröger N; Zander AR Cytotherapy; 1999; 1(2):135-9. PubMed ID: 19746590 [TBL] [Abstract][Full Text] [Related]
37. Multimarker quantitative real-time PCR detection of circulating melanoma cells in peripheral blood: relation to disease stage in melanoma patients. Koyanagi K; Kuo C; Nakagawa T; Mori T; Ueno H; Lorico AR; Wang HJ; Hseuh E; O'Day SJ; Hoon DS Clin Chem; 2005 Jun; 51(6):981-8. PubMed ID: 15817820 [TBL] [Abstract][Full Text] [Related]
38. The Results of Stricter Inclusion Criteria in an Immunomagnetic Detection Study of Micrometastatic Cells in Bone Marrow of Uveal Melanoma Patients - Relevance for Dormancy. Eide N; Faye RS; Høifødt HK; Sandvik L; Qvale GA; Faber R; Jebsen P; Kvalheim G; Fodstad Ø Pathol Oncol Res; 2019 Jan; 25(1):255-262. PubMed ID: 29098521 [TBL] [Abstract][Full Text] [Related]
39. The clinical utility of multimarker RT-PCR in the detection of occult metastasis in patients with melanoma. Taback B; Morton DL; O'Day SJ; Nguyen DH; Nakayama T; Hoon DS Recent Results Cancer Res; 2001; 158():78-92. PubMed ID: 11092035 [TBL] [Abstract][Full Text] [Related]
40. Sensitive and specific detection of circulating cancer cells in patients with hepatocellular carcinoma; detection of human telomerase reverse transcriptase messenger RNA after immunomagnetic separation. Waguri N; Suda T; Nomoto M; Kawai H; Mita Y; Kuroiwa T; Igarashi M; Kobayashi M; Fukuhara Y; Aoyagi Y Clin Cancer Res; 2003 Aug; 9(8):3004-11. PubMed ID: 12912949 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]